J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helpman, L.
Right arrow Articles by Gutman, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helpman, L.
Right arrow Articles by Gutman, G.
Agricola
Right arrow Articles by Helpman, L.
Right arrow Articles by Gutman, G.
J Med Microbiol 54 (2005), 803-804; DOI: 10.1099/jmm.0.46060-0
© 2005 Society for General Microbiology
ISSN 0022-2615

Chorioamnionitis associated with Crohn's disease and azathioprine treatment: a case report

Limor Helpman, David Pauzner, Joseph B Lessing, Michael J Kupferminc and Guy Gutman

Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Correspondence Guy Gutman gutguy10{at}yahoo.com

Received February 26, 2005
Accepted May 14, 2005

This paper reports a case of S. constellatus chorioamnionitis in a pregnant Crohn's disease patient who was taking azathioprine. Chorioamnionitis is a major cause of perinatal morbidity. Azathioprine, an immunosuppressive antimetabolite, is widely used to treat inflammatory bowel disease. Streptococcus constellatus is a Gram-positive bacterium that has not previously been associated with chorioamnionitis. A high index of suspicion for chorioamnionitis and unusual pathogens should be maintained in the management of obstetric patients on immunosuppressive agents.


    Case report
 TOP
 Case report
 Discussion
 References
 
The patient, a 27-year-old, gravida I, para 0, at 29 weeks and 4 days of gestation was hospitalized due to fever, abdominal pain and contractions of 2 days’ duration. She had a 5-year history of Crohn's disease, for which she took azathioprine, 50 mg three times daily, and mesalamine, 1 g three times daily.

On admission, the patient's blood pressure was 125/75 mmHg and body temperature was 38.5 °C. Foetal heart rate was 170 beats min–1 with good variability and short variable decelerations. Mild uterine contractions were noted every 3–6 min. Pelvic examination was significant for a dilatation of 1 cm, 0 % effacement and cephalic presentation. The patient denied rupture of membranes. Ultrasonography revealed a single intrauterine foetus, cephalic presentation, posterior placenta and a biophysical profile score of 8/8 with an amniotic fluid index of 12. Significant laboratory values included negative urinalysis and a white blood cell count of 3400 mm–1 (90 % neutrophils). The patient's chest X-ray was normal.

The patient was given intravenous antibiotics: loading dose of 5 000 000 IU penicillin G sodium followed by 2 500 000 IU six times daily, and 240 mg gentamicin once daily. Penicillin was given according to the department's protocol for pre-term delivery, and gentamicin was added for suspected infection based on maternal fever at presentation. The origin of the presumed infectious process was unidentified at this point.

Spontaneous rupture of membranes accompanied by a foul odour occurred 2 h later. Chorioamnionitis was diagnosed and an emergency caesarean section was performed when a non-stress test (NST) revealed deep and prolonged decelerations. A 1286 g female infant, with Apgar scores of 5 and 7 at 1 min and 5 min, respectively, was delivered. Streptococcus constellatus sensitive to penicillin was later cultured from the amniotic fluid and the placenta.

Anaerobic cultures of the endometrium side of the placenta and neonatal blood cultures were negative. Placental pathological features were described as ‘placenta showing acute changes of chorioamnionitis'.

The neonate was transferred to the neonatal intensive care unit with normal vital signs and spontaneous respiration. She needed no respiratory support throughout her course and remained haemodynamically stable. An echocardiogram was performed due to a systolic murmur on auscultation and revealed normal ventricular function, a patent foramen ovale and a small muscular ventricular septal defect. Gastrointestinal and metabolic functions were normal and she was neurologically intact.

Given the presumptive diagnosis of chorioamnionitis, blood cultures were taken after delivery and antibiotic treatment with penicillin and gentamicin was continued. When streptococci were cultured from the amniotic fluid and placenta, this treatment was continued for 7 days postpartum and until final culture results were obtained. The patient's fever resolved 48 h after treatment initiation.

Neonatal blood cultures were all negative. The remainder of the infant's hospital stay was uneventful, and she was discharged on postpartum day 49 weighing 2260 g. The mother's hospital stay was also uneventful, and she was discharged on postpartum day 9.


    Discussion
 TOP
 Case report
 Discussion
 References
 
Chorioamnionitis is considered a common cause of pre-term birth, which accounts for 70 % of perinatal mortality and 50 % of long-term neurological morbidity (Goldenberg et al., 2000) and, in term infants, constitutes an important risk factor for neurological morbidity (Grether & Nelson, 1997). An increasing body of evidence has recently suggested that not only is clinical infection responsible for pre-term birth but also for many serious neonatal sequelae, including periventricular leukomalacia, cerebral palsy, respiratory distress and even bronchopulmonary dysplasia and necrotizing enterocolitis (Bracci & Buonocore, 2003).

Intrauterine infection induces an intra-amniotic inflammatory response involving the activation of a number of cytokines and chemokines, which, in turn, may trigger pre-term contractions, cervical ripening, rupture of the membranes and the neonatal sequelae mentioned above (Hagberg et al., 2005).

The predictors of chorioamnionitis include pre-term labour or rupture of membranes, abnormal vaginal flora [e.g. Streptococcus agalactiae (GBS)], sexually transmitted disease, bacterial vaginosis, obstetric manipulations (e.g. vaginal examinations, internal foetal monitoring) in the presence of ruptured membranes, and diminished host response (due to smoking, drug abuse, obesity, immunodeficiency states, etc.). Group B streptococci and Enterobacteriaceae are the most important organisms associated with polymicrobial infection (Gibbs et al., 2004; Newton, 1993). Chorioamnionitis is associated with intubation in the delivery room, pneumonia and sepsis (Alexander et al., 1999; Petrova et al., 2001). These outcomes are kept to a minimum if maternal antibiotic chemotherapy is initiated intrapartum with agents that are safe for the foetus and effectively cross the placenta (Mercer et al., 1997). Antipyretics, such as acetaminophen, will reduce the hyperthermic stress on the foetus, while persistent foetal tachycardia after antipyretics may indicate foetal infection. Continuous electronic foetal monitoring is appropriate in cases of chorioamnionitis, and providers should be prepared for neonatal resuscitation, early neonatal intravenous antibiotics and respiratory support at delivery (Newton, 1993).

Crohn's disease commonly affects women of childbearing age. Women with Crohn's disease can expect to conceive successfully, carry to term and deliver a healthy baby. Control of disease activity before conception and during pregnancy is critical in order to optimize both maternal and foetal health. Most drugs, including sulfasalazine, mesalazine, corticosteroids and immunosuppressors, such as azathioprine and 6-mercaptopurine, are considered safe, whereas methotrexate is contraindicated (Mottet et al., 2005).

Azathioprine is the most commonly used immunomodulatory drug for treating inflammatory bowel disease. Its mode of action is thought to be multifactorial, and it is also known to alter lymphocyte function and affect natural killer cell function (Nielsen et al., 2001). It is used in pregnant patients with Crohn's disease to reduce disease activity, maintain remission and prevent relapse. We found no prior report on chorioamnionitis associated with azathioprine treatment.

S. constellatus is a species of Gram-positive bacteria in the Streptococcus milleri’ group, whose members are variably haemolytic and microaerophilic and tend to produce serious invasive infections or localized abscesses in almost any part of the body (Bert et al., 1998). Although placental pathological features suggested chorioamnionitis and S. constellatus was isolated from our patient's amniotic fluid, there was no evidence of foetal infection. Moreover, the route or source of infection was not identified: the medical centre's epidemiology unit reported no similar concurrent infections in other hospital wards.

The decision to deliver was based on the presumed diagnosis of intra-amniotic infection, as indicated by maternal fever (38.5 °C) and persistent uterine contractions; the decision to deliver by emergency caesarean section was motivated by the non-reassuring foetal heart rate. The maternal and foetal courses were uncomplicated, with each receiving postpartum penicillin treatment.

A high index of suspicion for chorioamnionitis and unusual pathogens should be maintained in the management of obstetric patients on immunosuppressive agents in order to ensure appropriate and timely intervention and increase the chances of a benign clinical course.


    References
 TOP
 Case report
 Discussion
 References
 

  • Alexander, J. M., McIntire, D. M. & Leveno, K. J. (1999). Chorioamnionitis and the prognosis for term infants. Obstet Gynecol 94, 274–278.[Abstract/Free Full Text]

  • Bert, F., Bariou-Lancelin, M. & Lambert-Zechovsky, N. (1998). Clinical significance of bacteremia involving the ‘Streptococcus milleri’ group: 51 cases and review. Clin Infect Dis 27, 385–387.[Medline]

  • Bracci, R. & Buonocore, G. (2003). Chorioamnionitis: a risk factor for fetal and neonatal morbidity. Biol Neonate 83, 85–96.[CrossRef][Medline]

  • Gibbs, R. S., Schrag, S. & Schuchat, A. (2004). Perinatal infections due to group B streptococci. Obstet Gynecol 104, 1062–1076.[Abstract/Free Full Text]

  • Goldenberg, R. L., Hauth, J. C. & Andrews, W. W. (2000). Intrauterine infection and preterm delivery. N Engl J Med 342, 1500–1507.[Free Full Text]

  • Grether, J. K. & Nelson, K. B. (1997). Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 278, 207–211.[Abstract]

  • Hagberg, H., Mallard, C. & Jacobsson, B. (2005). Role of cytokines in preterm labour and brain injury. Br J Obstet Gynecol 112 (Suppl 1), 16–18.

  • Mercer, B. M., Miodovnik, M., Thurnau, G. R. & 14 other authors (1997). Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes.A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA 278, 989–995.[Abstract]

  • Mottet, C., Juillerat, P., Gonvers, J. J., Froehlich, F., Burnand, B., Vader, J. P., Michetti, P. & Felley, C. (2005). Pregnancy and Crohn's disease. Digestion 71, 54–61.[Medline]

  • Newton, E. R. (1993). Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol 36, 795–808.[Medline]

  • Nielsen, O. H., Vainer, B. & Rask-Madsen, J. (2001). Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine. Aliment Pharmacol Ther 15, 1699–1708.[CrossRef][Medline]

  • Petrova, A., Demissie, K., Rhoads, G. G., Smulian, J. C., Marcella, S. & Ananth, C. V. (2001). Association of maternal fever during labor with neonatal and infant morbidity and mortality. Obstet Gynecol 98, 20–27.[Abstract/Free Full Text]





    This Article
    Right arrow Abstract Freely available
    Right arrow Full Text (PDF)
    Right arrow Alert me when this article is cited
    Right arrow Alert me if a correction is posted
    Right arrow Citation Map
    Services
    Right arrow Email this article to a friend
    Right arrow Similar articles in this journal
    Right arrow Similar articles in PubMed
    Right arrow Alert me to new issues of the journal
    Right arrow Download to citation manager
    Right arrow reprints & permissions
    Citing Articles
    Right arrow Citing Articles via CrossRef
    Right arrow Citing Articles via Google Scholar
    Google Scholar
    Right arrow Articles by Helpman, L.
    Right arrow Articles by Gutman, G.
    Right arrow Search for Related Content
    PubMed
    Right arrow PubMed Citation
    Right arrow Articles by Helpman, L.
    Right arrow Articles by Gutman, G.
    Agricola
    Right arrow Articles by Helpman, L.
    Right arrow Articles by Gutman, G.


    HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
    INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS